Abstract
The aim of this study was to evaluate the potential association of functional polymorphisms of macrophage migration inhibitory factor with systemic lupus erythematosus. Our study includes 711 systemic lupus erythematosus (SLE) patients and 755 healthy controls. We genotyped the migration inhibitory factor (MIF) −173G/C using a polymerase chain reaction (PCR) system with predeveloped TaqMan allelic discrimination assay and the MIF −794 CATTn microsatellite polymorphism using a PCR-fluorescent method. A statistically significant difference in the distribution of the MIF −173*C allele between SLE patients and controls (P=0.004, OR=1.34, 95% CI=1.05–1.27) was observed. In addition, the frequency of the MIF −173*C/C genotype was higher in SLE patient (P=0.002, OR=2.58, 95% CI=1.32–5.10). No differences in the distribution of CATTn were found. However, the haplotypes analyses showed that only the CATT7-MIF −173*C haplotype was associated with a higher susceptibility to SLE (P=0.001, OR 1.84, 95% CI 1.35–2.79). No association with clinical features was detected in any case. These results suggest that both, MIF −173*C allele and CATT7-MIF −173*C haplotype, confer susceptibility to SLE in our population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wakeland EK, Liu K, Graham RR, Behrens TW . Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397–408.
Tsao BP . Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004; 16: 513–521.
Croker JA, Kimberly RP . Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529–537.
Prokunina L, Alarcon-Riquelme M . The genetic basis of systemic lupus erythematosus – knowledge of today and thoughts for tomorrow. Hum Mol Genet 2004; 13 (Spec No 1): R143–R148.
Illei GG, Tackey E, Lapteva L, Lipsky PE . Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum 2004; 50: 1709–1720.
Illei GG, Tackey E, Lapteva L, Lipsky PE . Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 2004; 50: 2048–2065.
Calandra T, Roger T . Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791–800.
Donn RP, Ray DW . Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 2004; 182: 1–9.
Gregersen PK, Bucala R . Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 2003; 48: 1171–1176.
Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849–7854.
Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R . An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999; 5: 181–191.
Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003; 48: 1881–1889.
Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF . Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004; 31: 268–273.
Renner P, Roger T, Calandra T . Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41 (Suppl 7): S513–S519.
Donn RP, Shelley E, Ollier WE, Thomson W . A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782–1785.
Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402–2409.
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170–176.
Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004; 123: 484–487.
Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y et al. Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39: 242–246.
Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M . Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004; 169: 1014–1018.
Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005; 52: 3020–3029.
Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003; 4: 487–491.
Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506–511.
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561–571.
Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, Caliz R et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219–224.
Hoi AY, Morand EF, Leech M . Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? Immunol Cell Biol 2003; 81: 367–373.
Acknowledgements
This work was supported by Grant SAF03-3460 from Plan Nacional de I+D+I, and in part by the Junta de Andalucía, grupo CTS-180. We thank Ma Paz Ruiz and Sasha Zhernakova for her excellent technical assistance. Finally, we thank Cisca Wijmenga for support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez, E., Gómez, L., Lopez-Nevot, M. et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 7, 433–436 (2006). https://doi.org/10.1038/sj.gene.6364310
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364310
Keywords
This article is cited by
-
The immunobiology of MIF: function, genetics and prospects for precision medicine
Nature Reviews Rheumatology (2019)
-
Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
Scientific Reports (2016)
-
Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan
Cell Biochemistry and Biophysics (2014)
-
A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease
Arthritis Research & Therapy (2013)
-
Functional variants of MIF, INFG and TFNA genes are not associated with disease susceptibility or hearing loss progression in patients with Ménière’s disease
European Archives of Oto-Rhino-Laryngology (2013)